Infliximab Biosimilar - Research Grade

Human

TNF alpha

1.0 - 5.0 mg/ml

Human IgG1 Kappa

Humanized

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.

Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human TNF-alpha. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Infliximab.

Blue ice

A pivotal pro-inflammatory cytokine, tumour necrosis factor alpha (TNF-α) is implicated across a broad range of autoimmune and inflammatory conditions studied preclinically. This research-grade anti-human TNF-α recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of infliximab, built around the TNF-α target for research use only. Manufactured to in vivo standards as an ultra-pure, low-endotoxin human IgG1-kappa, it is supplied in scalable milligram to gram quantities to serve high-throughput and bulk laboratories. The antibody acts as a consistent control and active reagent across in vitro neutralisation screening, in vivo inflammatory disease models, and biologics characterisation.

Cachectin, TNFa, Tumor necrosis factor ligand superfamily member 2, Tnfsf2

P01375

ICH3001-100ml ICH3002-100ml ICH3003-100ml

https://www.imgt.org/mAb-DB/